![]() |
市場調查報告書
商品編碼
1896915
醫院感染控制市場規模、佔有率和成長分析(按產品、應用、技術、疾病、最終用戶和地區分類)—產業預測(2026-2033 年)Hospital-Acquired Infection Control Market Size, Share, and Growth Analysis, By Product, By Application, By Technology, By Disease, By End User, By Region - Industry Forecast 2026-2033 |
||||||
預計到 2024 年,醫院感染控制市場規模將達到 326.2 億美元,到 2025 年將達到 350 億美元,到 2033 年將達到 615 億美元,在預測期(2026-2033 年)內,複合年成長率為 7.3%。
醫院感染控制市場正經歷顯著成長,這主要得益於人們對預防交叉感染重要性的認知不斷提高,以及醫療機構感染疾病發生率居高不下。政府對感染控制舉措的支持也對市場動態起到了關鍵作用。各級醫療機構制定的嚴格感染預防標準和通訊協定,營造了以安全和衛生為中心的文化。此外,先進監測解決方案的日益普及也強化了這一趨勢,使醫療機構能夠實施積極主動的策略,有效預防和控制醫院感染。這些因素共同促成了醫院在維護病人安全和改善整體健康結果方面日益增強的投入。
醫院感染控制市場促進因素
全球醫院感染控制市場正經歷顯著成長,主要受每年手術量增加的推動。這一成長歸因於多種因素,包括肥胖症和其他需要手術治療的文明病發生率的上升。隨著手術量的增加,醫院感染的風險也隨之增加,凸顯了有效感染控制的迫切需求。因此,醫療機構正在增加對先進感染預防解決方案的投資,以提高病患安全並改善病患的整體治療效果。
限制醫院感染控制市場的因素
隨著醫療機構擴大選擇對可重複使用的醫療設備進行再處理以降低成本和減少廢棄物,醫院感染控制市場面臨挑戰。這種做法適用於多種器械,包括手術鉗、內視鏡和聽診器。儘管再處理具有經濟和環境效益,但人們仍對再處理器械的安全性和有效性感到擔憂。這些擔憂可能導致醫護人員和病患猶豫不決,進而影響醫療機構感染控制措施的整體實施。因此,人們對再處理相關風險的認知可能會限制市場成長和感染預防策略的創新。
醫院感染控制市場趨勢
醫院感染預防市場的一大趨勢是環氧乙烷滅菌技術的重新應用。該技術具有無與倫比的有效性,尤其適用於對溫度敏感的醫療器材。環氧乙烷滅菌技術的復興源於對能夠維持精密設備完整性的先進滅菌方法的需求不斷成長。然而,人們對環氧乙烷暴露相關健康風險的認知也顯著提高,這迫使醫療機構加強安全措施並採用新技術。隨著醫院在有效性和安全性之間尋求平衡,預計輸送系統和監測方法的創新將提升環氧乙烷在感染預防策略中的吸引力和接受度。
Hospital-Acquired Infection Control Market size was valued at USD 32.62 Billion in 2024 and is poised to grow from USD 35 Billion in 2025 to USD 61.5 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).
The Hospital Acquired Infection (HAI) control market is witnessing significant growth driven by increased awareness of the importance of preventing cross-infections and the high incidence of infectious diseases in healthcare settings. Government support for infection control initiatives also plays a crucial role in enhancing market dynamics. Strict infection prevention standards and protocols established across diverse healthcare levels foster a culture centered on safety and hygiene. Furthermore, the escalating use of advanced monitoring solutions strengthens this trend, enabling healthcare facilities to implement proactive strategies for effectively preventing and managing HAIs. These combined factors underscore a growing commitment to maintaining patient safety and improving overall health outcomes within hospitals.
Top-down and bottom-up approaches were used to estimate and validate the size of the Hospital-Acquired Infection Control market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Hospital-Acquired Infection Control Market Segments Analysis
Global Hospital-Acquired Infection Control Market is segmented by Product, Application, Technology, Disease, End User and region. Based on Product, the market is segmented into Protective Barrier, Sterilization, Disinfectants, Disinfectors, Endoscope Reprocessing Products and Other Infection Control Products. Based on Application, the market is segmented into Disease Testing and Drug-Resistance Testing. Based on Technology, the market is segmented into Phenotypic Methods and Genotypic Methods. Based on Disease, the market is segmented into Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection and Others. Based on End User, the market is segmented into Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, Nursing Homes & Maternity Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Hospital-Acquired Infection Control Market
The global Hospital-Acquired Infection Control market has seen significant growth driven by the rising number of surgical procedures performed each year, which has reached an impressive volume globally. This surge can be attributed to various factors, including the increasing incidence of health conditions such as obesity and other lifestyle-related diseases, which often require surgical treatment. As more surgeries are conducted, the associated risk of hospital-acquired infections also escalates, highlighting the critical need for effective infection control measures. Consequently, healthcare facilities are increasingly investing in advanced infection prevention solutions to enhance patient safety and improve overall outcomes.
Restraints in the Hospital-Acquired Infection Control Market
The Hospital-Acquired Infection Control market faces a challenge as healthcare providers frequently choose to reprocess reusable medical devices to cut costs and minimize waste. This practice involves a diverse array of instruments, including surgical forceps, endoscopes, and stethoscopes. Despite the financial and environmental benefits, there are ongoing concerns about the safety and effectiveness of these reprocessed instruments. Such apprehensions can lead to hesitancy among healthcare professionals and patients alike, potentially impacting the overall adoption of infection control measures within medical facilities. As a result, the perceived risks associated with reprocessing may constrain market growth and innovation in infection prevention strategies.
Market Trends of the Hospital-Acquired Infection Control Market
The market for Hospital-Acquired Infection (HAI) control is witnessing a significant trend towards the reintroduction of ethylene oxide sterilization due to its unparalleled effectiveness, particularly for temperature-sensitive medical instruments. This resurgence is driven by an increasing demand for advanced sterilization methods that maintain the integrity of delicate devices. However, the evolving landscape is marked by a growing awareness surrounding the health risks tied to ethylene oxide exposure, prompting healthcare facilities to adopt improved safety protocols and technologies. As hospitals seek to balance efficacy with safety, innovations in delivery systems and monitoring practices are expected to enhance the appeal and acceptance of ethylene oxide in infection control strategies.